Skip to content

Utilizing Telemedicine for Hypertension Treatment Lifestyle Modification in Central Harlem

Hypertension Control in the Age of COVID-19: Utilizing Telemedicine for Hypertension Treatment Lifestyle Modification in Central Harlem

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05062473
Enrollment
0
Registered
2021-09-30
Start date
2021-10-04
Completion date
2023-03-01
Last updated
2023-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The purpose of this study is to test the feasibility of creating a health education telemedicine curriculum that can be delivered by Weill Cornell Medicine faculty and medical students and NY-Presbyterian Hospital resident physicians to community dwelling adults in an under-resourced local community.

Interventions

BEHAVIORALLifestyle Modification Webinars Focused on Hypertension Control

Participation in a 12-week health education telemedicine curriculum

Sponsors

Health Resources and Services Administration (HRSA)
CollaboratorFED
Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female greater than or equal to 18 years of age. * Self-report of a hypertension diagnosis.

Exclusion criteria

* Pregnant or breastfeeding. * End-stage renal disease on hemodialysis.

Design outcomes

Primary

MeasureTime frameDescription
Change in Participant's Rate of Completion of Weekly Steps RecordingsBaseline to 12 weeks.Participant's rate of completion of the weekly step recording logs will be measured and analyzed.
Participant's Satisfaction with the Curriculum at 12 WeeksWeek 12Participant's satisfaction with the curriculum will be measured via 5-point Likert scale survey that was created by our research team. Scores will range from a low of Strongly disagree to a high of Strongly agree.
Change in Number of Participants Virtually Attending the Health Education SeminarsBaseline to 12 weeks.Virtual attendance to the health education seminars will be collected. The number of participants who virtually attend all health education seminars over the 12 week period will be collected and change in number of participants attending will be assessed.
Change in Participant's Rate of Completion of Weekly Blood Pressure RecordingsBaseline to 12 weeks.Participant's rate of completion of the weekly blood pressure recording logs will be measured and analyzed.

Secondary

MeasureTime frameDescription
Mean Change in Systolic Blood Pressure Measurement.Baseline to week 12Participants will self-report weekly up to 4 blood pressure readings taken at baseline through week 12 with their automatic blood pressure arm cuff. The change in systolic blood pressure measurements in this time frame will be assessed.
Mean Change in Diastolic Blood Pressure Measurement.Baseline to week 12Participants will self-report weekly up to 4 blood pressure readings taken at baseline through week 12 with their automatic blood pressure arm cuff. The change in diastolic blood pressure measurements in this time frame will be assessed.
Mean Change in Number of Daily Steps Measured by Pedometer.Baseline to week 12Participants will self-report weekly the number of steps taken as measured by their wrist pedometer at baseline through week 12.
Change in Self-Reported Health Attitudes and Behaviors As Assessed by Survey.Baseline, week 12The name of the survey is Knowledge, attitudes, and perceptions towards hypertension and cardiovascular disease. The survey was adapted from the Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. It consists of both quantitative and qualitative questions assessing participants' demographics, participants' knowledge and attitudes about diet and exercise, and participants' knowledge about hypertension and other related cardiac diseases (i.e. stroke, coronary artery disease). The survey will be administered at enrollment and post-intervention at week 12. Pre- and post-surveys will be compared for accuracy of answers and change in self-reported behaviors.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026